![Kevin Shaw](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Shaw
General Counsel bei
NEXTCURE, INC.
Profil
Kevin G.
Shaw is Senior Vice President & General Counsel at NextCure, Inc. since 2023.
Previously, Mr. Shaw was Vice President & Deputy General Counsel at Precigen, Inc. from 2012 to 2022.
Education includes undergraduate studies at the University of Pennsylvania and graduate studies at George Washington University Law School.
Aktive Positionen von Kevin Shaw
| Unternehmen | Position | Beginn |
|---|---|---|
| NEXTCURE, INC. | General Counsel | 01.05.2022 |
Ehemalige bekannte Positionen von Kevin Shaw
| Unternehmen | Position | Ende |
|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | 01.05.2022 |
Ausbildung von Kevin Shaw
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
60
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Washington University Law School
 George Washington University Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
